Aspirin exacerbated respiratory disease (AERD) consists of nasal polyposis, rhinosinusitis, asthma, and aspirin (ASA) sensitivity.
Objective
This article details how to diagnose and treat AERD and describes the procedures associated with ASA challenge and desensitization, benefits associated with ASA desensitization, and appropriate doses for treatment.
Methods
Criteria for diagnosis of AERD as well as desensitization protocols for oral ASA challenge and combined intranasal ketorolac and oral ASA challenge, are detailed in this article based on literature review.
Results
AERD requires a multidimensional approach to treat the disease given the multiple conditions. With successful ASA desensitization and maintenance of ASA administration, all patients are able to achieve ASA tolerance and select patients are able to achieve improvement in clinical markers such as global scores and reduction in use of topical and systemic corticosteroids.
Get full access to this article
View all access options for this article.
References
1.
SamterM., and BeersRFJr.Intolerance to aspirin: Clinical studies and consideration of its pathogenesis.Ann Intern Med68: 975–983, 1968.
2.
Berges-GimenoM.P., SimonR.A., and StevensonD.D.. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol89: 474, 2002.
3.
SzczeklikA.. Aspirin-induced asthma as a viral disease.Clin Allergy18: 15–20, 1998.
4.
SzczeklikA., NizankowskaE., and DuplagaM.. On behalf of the AIANE investigators: Natural history of aspirin-induced asthma.Eur Respir J16: 432–436, 2000.
5.
BlancaM., PerezE., GarciaJ.J.. Angioedema and IgE antibodies to aspirin: A case report. Ann.Allergy62: 295–298, 1989.
6.
RodriguezS.C., OlguinA.M., MirallesC.P., and ViladrichP.F.. Characteristics of meningitis caused by Ibuprofen: Report of 2 cases and review of the literature.Medicine85: 214–220, 2006.
7.
MastalerzL., SetkowiczM., SanakM., and SzczeklikA.. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma.J Allergy Clin Immunol113: 771–775, 2004.
8.
KatialR., StrandM., PrasertsuntarasaiT.. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.J Allergy Clin Immunol126: 738–744, 2010.
9.
GyllforsP., BochenekG., OverholtJ.. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.J Allergy Clin Immunol111: 1116–1121, 2003.
10.
WoessnerK.M., SimonR.A., and StevensonD.D.. The safety of celecoxib in patients with aspirin-sensitive asthma.Arthritis Rheum46: 2201–2206, 2002.
11.
StevensonD.D., and SimonR.A.. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.J Allergy Clin Immunol108: 47–51, 2001.
12.
National Heart, Lung, and Blood Institute.Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program Expert Panel Report 3, NIH Publication No. 08–4051, National Heart, Lung, and Blood Institute, Bethesda, MD, 2007. Available online at www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm; accessed March 21, 2011.
13.
Global Initiative for Asthma (GINA).Global strategy for asthma management and prevention.National Institutes of Health (NIH), Bethesda, MD, 2008. Available online at www.ginasthma.org; accessed June 1, 2009.
14.
Rhinosinusitis Task Force Committee.Report of the Rhinosinusitis Task Force Committee Meeting. Alexandria, Virginia, August 17, 1996.Otolaryngol Head Neck Surg117: S1–S68, 1997.
15.
RosenfeldR.M., AndesD., BhattacharyyaN.. Clinical practice guideline: Adult sinusitis.Otolaryngol Head Neck Surg137: S1–S31, 2007.
16.
FokkensW., LundV., BachertC.. EAACI position paper on rhinosinusitis and nasal polyps executive summary.Allergy60: 583, 2005.
17.
KatotomichelakisM., RigaM., DavrisS.. Allergic rhinitis and aspirin-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery.Am J Rhinol Allergy23: 348–353, 2009.
18.
ZeissC.R., and LockeyR.F.. Refractory period to aspirin in a patient with aspirin-induced asthma.J Allergy Clin Immunol57: 440–448, 1976.
19.
BiancoS., TobuschiM., and PetrigniG.. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test.IRCS J Med Sci5: 129, 1977.
20.
StevensonD.D.. Aspirin desensitization in patients with AERD.Clin Rev Allergy Immunol24: 159–168, 2003.
21.
PfaarO., and KlimekL.. Eicosanoids, aspirin-intolerance and the upper airways—Current standards and recent improvements of the desensitization therapy.J Physiol Pharmacol57(suppl 12): 5–13, 2006.
22.
MilewskiM., MastalerzL., NizankowskaE., and SzczeklikA.. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.J Allergy Clin Immunol101: 581–586, 1998.
23.
NizankowskaE., Bestynska-KrypelA., CmielA., and SzczeklikA.. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.Eur Respir J15: 863–869, 2000.
24.
ParikhA.A., and ScaddingG.K.. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial.Laryngoscope115: 1385–1390, 2005.
25.
MathisonD.A., and StevensonD.D.. Hypersensitivity to nonsteroidal anti-inflammatory drugs: Indications and methods for oral challenges.J Allery Clin Immunol64: 669–674, 1977.
26.
PleskowW.W., StevensonD.D., MathisonD.A.. Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of refractory period.J Allergy Clin Immunol69: 11–19, 1982.
27.
PhillipsG.D., FoordR., and HolgateS.T.. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late phase reaction, and the role of histamineJ Allergy Clin Immunol84: 232–241, 1989.
28.
MillewskiM., MastalerzL., NizankowskaE., and SzczeklikA.. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.J Allergy Clin Immunol101: 581–586, 1998.
29.
PatriarcaG., NuceraE., SchincoG.. Prevention of relapse in nasal polyposis.Lancet337: 1488, 1991.
30.
NuceraE., SchiavinoD., MilaniA.. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: Two controlled long term prospective follow up studies.Thorax55(suppl 2): S75–S78, 2000.
31.
ParikhA.A., and ScaddingG.K.. Intranasal lysine-aspirin in aspirin sensitive nasal polyposis: A controlled trial.Laryngoscope115: 1385, 2005.
32.
LeeR.U., WhiteA.A., DingD.. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol105: 130–135, 2010.
33.
WilliamsA., WoessnerK.M., SimonR.A., and StevensonD.D.. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.J Allergy Clin Immunol120: 273–277.
34.
MacyE., BernsteinJ.A., CastellsM.C.. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper.Ann Allergy Asthma Immunol98: 172–174, 2007.
35.
WhiteA.A., StevensonD.D., andSimonR.A.. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol95: 330–335, 2005.
36.
WhiteA., BigbyT., and StevensonD.D.. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol97: 190–195, 2006.
37.
HorseW.. Surgical treatment of nasal polyposis in patients with aspirin intolerance.Thorax55(suppl 2): S87–S90, 2000.
38.
McMainsK.C., and KountakisS.E.. Medical and surgical considerations in patients with Samter's triad.Am J Rhinol20: 573–576, 2006.
39.
KlimekL., and PfaarO.. Aspirin intolerance: Does desensitization alter the course of the disease?Immunol Allergy Clin North Am29: 669–675, 2009.
40.
Berges-GimenoM.P., SimonR.A., and StevensonD.D.. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol111: 180–186, 2003.
41.
GosepathJ., SchaeferD., AmedeeR.G., and MannW.J.. Individual monitoring of aspirin desensitization.Arch Otolaryngol Head Neck Surg127: 316–321, 2001.
42.
RozasiA., PolzehlD., DeutschleT.. Long-term treatment with aspirin desensitization: A prospective clinical trial comparing100mg and 300mg aspirin daily.Allergy63: 1228–1234, 2008.
43.
LeeJ.A., SimonR.A., and StevensonD.D.. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol119: 157, 2007.
